data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Regenxbio
(NASDAQ:RGNX)
$27.54
0.51[1.89%]
At close: Jul 6
$27.54
After Hours: 4:01PM EDT
Day High/Low26.6 - 28.28
52 Week High/Low18.69 - 46.46
Open / Close26.74 / 27.54
Float / Outstanding28.3M / 43.1M
Vol / Avg.298.4K / 432.2K
Mkt Cap1.2B
P/E11.65
50d Avg. Price22.99
Div / Yield-
Payout Ratio-
EPS-1.79
Total Float28.3M

Regenxbio (NASDAQ:RGNX), Quotes and News Summary

Regenxbio (NASDAQ: RGNX)

Day High/Low26.6 - 28.28
52 Week High/Low18.69 - 46.46
Open / Close26.74 / 27.54
Float / Outstanding28.3M / 43.1M
Vol / Avg.298.4K / 432.2K
Mkt Cap1.2B
P/E11.65
50d Avg. Price22.99
Div / Yield-
Payout Ratio-
EPS-1.79
Total Float28.3M
Benzinga - Jun 23, 2022, 11:03AM
Benzinga - Jun 23, 2022, 7:23AM
Benzinga - Jun 23, 2022, 7:12AM
Benzinga - May 24, 2022, 7:56AM
Benzinga - May 5, 2022, 8:33AM
Benzinga - May 4, 2022, 4:19PM
Benzinga - Mar 23, 2022, 8:30AM
Benzinga - Mar 2, 2022, 4:39AM
Benzinga - Mar 1, 2022, 5:01PM
Benzinga - Mar 1, 2022, 4:33PM
Benzinga - Mar 1, 2022, 4:32PM
Benzinga - Feb 14, 2022, 11:46AM
Benzinga - Feb 10, 2022, 11:58AM
Sector: Health Care.Industry: Biotechnology
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-1.320-1.580 -0.2600
REV29.210M22.218M-6.992M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Regenxbio Questions & Answers

Q
How do I buy Regenxbio (RGNX) stock?
A

You can purchase shares of Regenxbio (NASDAQ: RGNX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Regenxbio's (RGNX) competitors?
Q
What is the target price for Regenxbio (RGNX) stock?
A

The latest price target for Regenxbio (NASDAQ: RGNX) was reported by Berenberg on Thursday, June 23, 2022. The analyst firm set a price target for 61.00 expecting RGNX to rise to within 12 months (a possible 121.50% upside). 13 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Regenxbio (RGNX)?
A

The stock price for Regenxbio (NASDAQ: RGNX) is $27.54 last updated July 6, 2022, 8:00 PM UTC.

Q
Does Regenxbio (RGNX) pay a dividend?
A

There are no upcoming dividends for Regenxbio.

Q
When is Regenxbio (NASDAQ:RGNX) reporting earnings?
A

Regenxbio’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Regenxbio (RGNX) going to split?
A

There is no upcoming split for Regenxbio.

Q
What sector and industry does Regenxbio (RGNX) operate in?
A

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.